British Journal of Anaesthesia, 1985, Vol. 57, No. 2 197-203
© 1985 The Board of Management and Trustees of the British Journal of Anaesthesia
research-article |
COMPARATIVE PHARMACOLOGY OF THE KETAMINE ISOMERS
Studies in Volunteers
Department of Anesthesia, Stanford University School of Medicine Stanford, California 94305, U.S.A.
Department of Pharmacology, University of California San Francisco, California 94143, U.S.A.
Correspondence to P.F.W. (Room S-268C).
The clinical and electroencephalographic (EEG) effects of the individual ketamine isomers were compared with the racemic mixture in five volunteers who received each drug on a separate occasion. Racemic ketamine 275 ± 25 mg, s(+) ketamine 140 ± 21 mg or R(–) ketamine 429 ± 37 mg produced an anaesthetic state lasting 6 ± 2 min (mean ± SD). However, the EEG evaluation of the R(–) isomer revealed less overall slowing, and an absence of the large slow wave complexes produced by the s(+) isomer and the racemic mixture. The pharmacokinetic profiles for the individual isomers of ketamine did not differ significantly from the racemic mixture. Even though the apparent anaesthetic state produced in these healthy volunteers did not differ qualitatively between the three drug groups, recovery times (assessed using a standardized battery of psychometric tests) were consistently shorter following the individual isomers compared with the racemic mixture. The serum ketamine concentrations associated with regaining consciousness and orientation were consistent with an s(+):R(–) isomer potency ratio of 4:1. In terms of their ability to impair psychomotor function, the s(+):R(–) potency ratio varied from 3:1 to 5:1. After comparable degrees of CNS depression, we conclude that the more potent s(+) isomer of ketamine was associated with a more rapid recovery of psychomotor skills than the currently used racemic mixture.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. W. Sear What makes a molecule an anaesthetic? Studies on the mechanisms of anaesthesia using a physicochemical approach Br. J. Anaesth., July 1, 2009; 103(1): 50 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. I. Eger II, D. E. Raines, S. L. Shafer, H. C. Hemmings Jr, and J. M. Sonner Is a New Paradigm Needed to Explain How Inhaled Anesthetics Produce Immobility? Anesth. Analg., September 1, 2008; 107(3): 832 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gilles and R. Luthringer Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs J Psychopharmacol, May 1, 2007; 21(3): 272 - 282. [Abstract] [PDF]
|
|
|
|
|
|
A. R. Absalom, M. Lee, D. K. Menon, S. R. Sharar, T. De Smet, J. Halliday, M. Ogden, P. Corlett, G. D. Honey, and P. C. Fletcher Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers Br. J. Anaesth., May 1, 2007; 98(5): 615 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pai and M. Heining Ketamine CEACCP, April 1, 2007; 7(2): 59 - 63. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Larenza, M. F. Landoni, O. L. Levionnois, M. Knobloch, P. W. Kronen, R. Theurillat, U. Schatzmann, and W. Thormann Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies Br. J. Anaesth., February 1, 2007; 98(2): 204 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Zarate Jr, J. B. Singh, P. J. Carlson, N. E. Brutsche, R. Ameli, D. A. Luckenbaugh, D. S. Charney, and H. K. Manji A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. Arch Gen Psychiatry, August 1, 2006; 63(8): 856 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Freye, L. Latasch, and J. V. Levy S(+)-ketamine attenuates increase in electroencephalograph activity and amplitude height of sensory-evoked potentials during rapid opioid detoxification. Anesth. Analg., May 1, 2006; 102(5): 1439 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sinner, O. Friedrich, W. Zink, E. Martin, R. H. A. Fink, and B. M. Graf Ketamine Stereoselectively Inhibits Spontaneous Ca2+-Oscillations in Cultured Hippocampal Neurons Anesth. Analg., June 1, 2005; 100(6): 1660 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Agarwal, M. Raza, S. Dhiraaj, R. Saxena, P. K. Singh, and R. Pandey Is Ketamine a Safe Anesthetic for Percutaneous Liver Biopsy in a Liver Transplant Recipient Immunosuppressed with Cyclosporine? Anesth. Analg., January 1, 2005; 100(1): 85 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lahtinen, H. Kokki, T. Hakala, and M. Hynynen S(+)-Ketamine as an Analgesic Adjunct Reduces Opioid Consumption After Cardiac Surgery Anesth. Analg., November 1, 2004; 99(5): 1295 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Williams, D. E. Mager, H. Parenteau, G. Gudi, T. S. Tracy, M. Mulheran, and I. W. Wainer EFFECTS OF PROTEIN CALORIE MALNUTRITION ON THE PHARMACOKINETICS OF KETAMINE IN RATS Drug Metab. Dispos., August 1, 2004; 32(8): 786 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. White Can the Use of Specific Isomers Improve the Safety and Efficacy of Nonsteroidal Antiinflammatory Drugs? Anesth. Analg., August 1, 2003; 97(2): 309 - 310. [Full Text] [PDF]
|
|
|
|
|
|
D. A. H. de Beer and M. L. Thomas Caudal additives in children--solutions or problems? Br. J. Anaesth., April 1, 2003; 90(4): 487 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Sewell and J. W. Sear Can molecular similarity-activity models for intravenous general anaesthetics help explain their mechanism of action? Br. J. Anaesth., February 1, 2002; 88(2): 166 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Marhofer, H. Freitag, A. Hochtl, M. Greher, W. Erlacher, and M. Semsroth S(+)-Ketamine for Rectal Premedication in Children Anesth. Analg., January 1, 2001; 92(1): 62 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sasaki, T. Andoh, I. Watanabe, Y. Kamiya, H. Itoh, T. Higashi, and T. Matsuura Nonstereoselective Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Ketamine Isomers Anesth. Analg., September 1, 2000; 91(3): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Obach Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes Drug Metab. Dispos., November 1, 1999; 27(11): 1350 - 1359. [Abstract] [Full Text]
|
|
E-letters:
Read all E-letters
- difference in isomers of ketamine
- Andrew T. Brackin
- British Journal of Anaesthesia, 22 Apr 2007 [Full text]